Published in Nature on April 09, 1966
Subfragments from the Fc fragment of human immunoglobulin G. Isolation and physicochemical charaterization. Biochem J (1968) 2.26
Antibodies of IgA and IgG class in normal human urine. Immunology (1967) 1.19
Light and heavy chain components of gamma globulins in urines of normal persons and patients with agammaglobulinemia. J Clin Invest (1967) 1.18
Quantitative studies on urinary immunoglobulins in hospital patients, including patients with urinary tract infection. Clin Exp Immunol (1970) 0.82
Urinary immunoglobulins in the adult pig. Immunology (1973) 0.78
Immunoglobulins of normal human urine and urethral secretions. Immunology (1971) 0.75
A research standard for human serum immunoglobulins IgG, IgA and IgM. Bull World Health Organ (1970) 7.25
Prevention of eczema. Lancet (1977) 4.89
Immunoglobulin D as a lymphocyte receptor. J Exp Med (1973) 4.62
Transient IgA deficiency and pathogenesis of infantile atopy. Lancet (1973) 4.07
Is migraine food allergy? A double-blind controlled trial of oligoantigenic diet treatment. Lancet (1983) 3.79
Primary immunodeficiencies. Report of a World Health Organization Committee. Pediatrics (1971) 3.69
Plasma immunoglobulin concentrations in a West African (Gambian) community and in a group of healthy British adults. Clin Exp Immunol (1968) 3.53
Radioactive single radial diffusion: a method for increasing the sensitivity of immunochemical quantification of proteins in agar gel. Bull World Health Organ (1969) 3.31
Association of low levels of mannan-binding protein with a common defect of opsonisation. Lancet (1989) 3.12
Molecular basis of opsonic defect in immunodeficient children. Lancet (1991) 3.00
Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series. BMJ (1997) 2.93
The Portex EpiFuse epidural connector: lessons on first use in a large district general hospital. Anaesthesia (2011) 2.87
An international reference preparation for human serum immunoglobulins G, A and M: content of immunoglobulins by weight. Bull World Health Organ (1972) 2.82
Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect Immun (2000) 2.71
Deficiency of mannose-binding lectin and burden of infection in children with malignancy: a prospective study. Lancet (2001) 2.60
Mannose binding protein gene mutations associated with unusual and severe infections in adults. Lancet (1995) 2.41
Immune exclusion is a function of IgA. Nature (1975) 2.36
Reactive haemolysis--a distinctive form of red cell lysis. Immunology (1968) 2.32
Subfragments from the Fc fragment of human immunoglobulin G. Isolation and physicochemical charaterization. Biochem J (1968) 2.26
IgD on the surface of peripheral blood lymphocytes of the human newborn. Nat New Biol (1973) 2.19
Comparison of ipecac-induced emesis with gastric lavage in the treatment of acute salicylate ingestion. J Pediatr (1969) 2.18
Predisposing factors and the development of reaginic allergy in infancy. Clin Allergy (1976) 2.15
Defective yeast opsonization and C2 deficiency in atopic patients. Clin Exp Immunol (1978) 2.14
High frequencies in African and non-African populations of independent mutations in the mannose binding protein gene. Hum Mol Genet (1992) 2.09
A research standard for human serum immunoglobulin D. Bull World Health Organ (1970) 2.09
A research standard for human serum immunoglobulin E. Bull World Health Organ (1970) 2.05
Mutation of gene of mannose-binding protein associated with chronic hepatitis B viral infection. Lancet (1996) 2.01
Mannose-binding lectin: targeting the microbial world for complement attack and opsonophagocytosis. Immunol Rev (2001) 1.90
Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA. J Immunol Methods (2004) 1.78
HLA antigens and atopic features in steroid-responsive nephrotic syndrome of childhood. Lancet (1976) 1.73
Atopy does not predispose to RSV bronchiolitis or postbronchiolitic wheezing. Br Med J (Clin Res Ed) (1981) 1.73
An approach to the problem of noncompliance in a pediatric outpatient clinic. Am J Dis Child (1971) 1.69
Mannose-binding lectin in innate immunity: past, present and future. Tissue Antigens (2006) 1.66
Studies on immunoglobulins of Nigerians. I. The immunoglobulin levels of a Nigerian population. J Trop Med Hyg (1966) 1.59
Intestinal sugar permeability: relationship to diarrhoeal disease and small bowel morphology. J Pediatr Gastroenterol Nutr (1985) 1.57
Mannose-binding lectin is present in the infected airway: a possible pulmonary defence mechanism. Thorax (2008) 1.54
Endotoxin immunity and the development of the systemic inflammatory response syndrome in critically ill children. Intensive Care Med (2006) 1.52
IgG antigens of the C gamma 2 and C gamma 3 homology regions interacting with rheumatoid factors. Clin Exp Immunol (1972) 1.51
Soluble antigens in the blood of African patients with severe plasmodium falciparum malaria. Lancet (1968) 1.50
Pepsin digestion of human G-myeloma proteins of different subclasses. I. The characteristic features of pepsin cleavage as a function of time. Clin Exp Immunol (1970) 1.50
Branhamella catarrhalis: antigenic determinants and the development of the IgG subclass response in childhood. J Infect Dis (1990) 1.49
Metabolism of human immunoglobulin D (IgD). J Clin Invest (1966) 1.46
Immunoglobulin levels and antibody to Candida albicans in human cervicovaginal secretions. Clin Exp Immunol (1972) 1.45
Localization of Gm markers to different molecular regions of the Fc fragment. Clin Exp Immunol (1971) 1.44
Plasma immunoglobulin concentrations in an African (Gambian) community in relation to season, malaria and other infections and pregnancy. Clin Exp Immunol (1970) 1.43
Mechanisms of protective immunity in experimental cutaneous leishmaniasis of the guinea-pig. I. Lack of effects of immune lymphocytes and of activated macrophages. Clin Exp Immunol (1975) 1.42
Preventive health care in the HMO: cost benefit issues. J Am Coll Health Assoc (1978) 1.39
Classification of the primary immune deficiencies: WHO recommendation. N Engl J Med (1970) 1.39
The level of mannan-binding protein regulates the binding of complement-derived opsonins to mannan and zymosan at low serum concentrations. Clin Exp Immunol (1990) 1.37
Pseudomonas infection, allergy, and cystic fibrosis. Arch Dis Child (1982) 1.37
Mannose-binding lectin regulates the inflammatory response of human professional phagocytes to Neisseria meningitidis serogroup B. J Infect Dis (2001) 1.35
Mechanisms of protective immunity in experimental cutaneous leishmaniasis of the guinea-pig. II. Selective destruction of different Leishmania species in activated guinea-pig and mouse macrophages. Clin Exp Immunol (1975) 1.35
Immunoglobulin D in serum, body fluids and lymphoid tissues. Clin Exp Immunol (1968) 1.34
Secretory IgA in human serum. J Immunol (1970) 1.32
Localisation of monocyte binding site of human immunoglobulin G. Nature (1974) 1.30
Use of utilization review to assess the quality of pediatric inpatient care. Pediatrics (1972) 1.30
Mechanisms of protective immunity in experimental cutaneous leishmaniasis of the guinea-pig. III. Inhibition of leishmanial lesion in the guinea-pig by delayed hypersensitivity reaction to unrelated antigens. Clin Exp Immunol (1977) 1.27
Plasma immunoglobulin concentrations in mothers and newborn children with special reference to placental malaria: Studies in the Gambia, Nigeria, and Switzerland. Bull World Health Organ (1973) 1.23
Light chain types in plasma cells that produce IgD. Immunology (1969) 1.23
Distinct physicochemical characteristics of human mannose binding protein expressed by individuals of differing genotype. Immunology (1995) 1.23
Antibody-induced movement of membrane components of Leishmania enriettii. J Exp Med (1974) 1.23
Intravaginal immunization of humans with Candida albicans. J Immunol (1972) 1.22
Studies on human IgD. II. The lack of skin sensitizing and complement fixing activities of immunoglobulin D. Immunochemistry (1969) 1.20
Immunological studies in cystic fibrosis. Arch Dis Child (1978) 1.20
Increased intestinal permeability in atopic eczema. J Invest Dermatol (1986) 1.19
Antibodies of IgA and IgG class in normal human urine. Immunology (1967) 1.19
Immunoglobulin E: a new class of human immunoglobulin. Immunology (1968) 1.19
The generation of a 'tolerogen' after the ingestion of ovalbumin is time-dependent and unrelated to serum levels of immunoreactive antigen. Clin Exp Immunol (1990) 1.19
A study of C3b deposition on yeast surfaces by sera of known opsonic potential. Clin Exp Immunol (1981) 1.18
Immune haemolysis in agar: demonstration of the protective action of antibodies. Immunology (1967) 1.17
Anti-microbial activities of mannose-binding lectin. Biochem Soc Trans (2003) 1.16
HLA in eczema and hay fever. Clin Exp Immunol (1977) 1.15
Activation of complement by mannose-binding lectin on isogenic mutants of Neisseria meningitidis serogroup B. J Immunol (1998) 1.13
Impaired pulmonary status in cystic fibrosis adults with two mutated MBL-2 alleles. Eur Respir J (2004) 1.12
Rheumatoid anti Gm gactors with specificity for the pFc' subfragment of human immunoglobulin G. Nature (1970) 1.11
Suboptimal C3b/C3bi deposition and defective yeast opsonization. I. Evidence for the absence of essential co-factor activity. Clin Exp Immunol (1985) 1.10
IgE levels in external secretions. Int Arch Allergy Appl Immunol (1973) 1.09
The disease of the NZB mouse. I. Examination of ovum fusion derived tetraparental NZB:CFW chimaeras. Clin Exp Immunol (1972) 1.09
Studies on the immunology of human malaria. I. Preliminary characterization of antigens in Plasmodium falciparum infections. Clin Exp Immunol (1969) 1.08
Concentration of serum-immunoglobulins in healthy young adult males estimated by assay against the international reference preparation. Lancet (1972) 1.07
Plasma immunoglobulin concentrations in twins. Clin Exp Immunol (1968) 1.07
Human constant regions influence the antibody binding characteristics of mouse-human chimeric IgG subclasses. Immunology (1996) 1.05
Rhesus leukocyte-associated herpesvirus. I. Isolation and characterization of a new herpesvirus recovered from rhesus monkey leukocytes. J Infect Dis (1973) 1.04
Infant feeding and atopy. Lancet (1982) 1.04
Simple method of subtyping human G-myeloma proteins based on sensitivity to pepsin digestion. Nature (1970) 1.03
The lipopolysaccharide structures of Salmonella enterica serovar Typhimurium and Neisseria gonorrhoeae determine the attachment of human mannose-binding lectin to intact organisms. Infect Immun (2000) 1.03
Antibody-induced movement of protozoan surface membrane antigens. Ann N Y Acad Sci (1975) 1.02
Genetic (Gm) antigens associated with subfragments from the Fc fragment of human immunoglobulin G. Nature (1969) 1.02
Patient care and student learning in a pediatric clinic. Pediatrics (1972) 1.02
Immunoglobulin classes in mammalian species identifed by cross-reactivity with antisera to human immunoglobulin. Immunochemistry (1973) 1.02
The role of pH in modified ELISA procedures used for the estimation of functional antibody affinity. J Immunol Methods (1993) 1.01
Specific suppression of rat IgE responses with milk from immunized females and with feeds of serum antibody. Immunology (1983) 1.01
Determination of IgG antiglobulins in rheumatoid disease using insolubilized human IgG. Clin Exp Immunol (1973) 1.01
Cells producing IgD immunoglobulins in human spleen. Nature (1966) 1.01
Polymorphonuclear neutrophil iodination response as an estimate of defective yeast opsonization. Clin Exp Immunol (1981) 1.00
A controlled trial of hyposensitization with adsorbed tyrosine Dermatophagoides pteronyssinus antigen in childhood asthma: in vivo aspects. Clin Allergy (1984) 1.00
Correlation between the avidity of mouse-human chimeric IgG subclass monoclonal antibodies measured by solid-phase elution ELISA and biospecific interaction analysis (BIA). J Immunol Methods (1997) 0.99